Pyroglutamylated RFamide Peptide (Human)

Documents

Pyr-Asp-Glu-Gly-Ser-Glu-Ala-Thr-Gly-Phe-Leu-Pro-Ala-Ala-Gly-Glu-Lys-Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH₂
: (M.W. 4503.8) C₁₉₉H₃₀₁N₅₅O₆₅
: Endogenous Ligand for AQ27 / SP9155 / GPR103

Package	Price(Yen)	Availability
Vial 0.1 mg	13,000	Ships within 1-3 business days
Bulk Request

Solubility: H₂O (0.1 mM)

S. Fukusumi, H. Yoshida, R. Fujii, M. Maruyama, H. Komatsu, Y. Habata, Y. Shintani, S. Hinuma, and M. Fujino, J. Biol. Chem., 278, 46387 (2003). (Original)
Y. Jiang, L. Luo, E.L. Gustafson, D. Yadav, M. Laverty, N. Murgolo, G. Vassileva, M. Zeng, T.M. Laz, J. Behan, P. Qiu, L. Wang, S. Wang, M. Bayne, J. Greene, F. Monsma, Jr., and F.L. Zhang, J. Biol. Chem., 278, 27652 (2003). (Orphan Receptor Ligand / 26-Residue Peptide, P518)
N. Chartrel, C. Dujardin, Y. Anouar, J. Leprince, A. Decker, S. Clerens, J.-C. Do-Réo, F. Vandesande, C. Llorens-Cortes, J. Costentin, J.-C. Beauvillain, and H. Vaudry, Proc. Natl. Acad. Sci. U.S.A., 100, 15247 (2003). (26-Residue Peptide, 26RFa)
S. Takayasu, T. Sakurai, S. Iwasaki, H. Teranishi, A. Yamanaka, S.C. Williams, H. Iguchi, Y.I. Kawasawa, Y. Ikeda, I. Sakakibara, K. Ohno, R.X. Ioka, S. Murakami, N. Dohmae, J. Xie, T. Suda, T. Motoike, T. Ohuchi, M. Yanagisawa, and J. Sakai, Proc. Natl. Acad. Sci. U.S.A., 103, 7438 (2006). (Pharmacol.)
R. Moriya, H. Sano, T. Umeda, M. Ito, Y. Takahashi, M. Matsuda, A. Ishihara, A. Kanatani, and H. Iwaasa, Endocrinology, 147, 2916 (2006). (Pharmacol.)
S. Fukusumi, R. Fujii, and S. Hinuma, Peptides, 27, 1073 (2006). (Review)
D.A. Bechtold and S.M. Luckman, J. Endocrinol., 192, 3 (2007). (Review)

Data Sheet